IndiaMART.com Sponsors India Packaging Show 2010

NEW DELHI, March 31, 2010 -

– 75 percent of total demand for packaging and associated equipment comes
from food processing industry and pharmaceutical industry.

– There are around 600-700 packaging machinery manufacturers out of which
95 percent [...]

Elsevier Adds FDA Advisory Committee Content to PharmaPendium(TM)

Offers Preclinical, Clinical Drug Development and Regulatory Affairs More Access to Comparative Data

NEW YORK, March 31, 2010 – PharmaPendium (www.info.pharmapendium.com/), Elsevier
announces a new release that adds extensive FDA Advisory Committee content to
the online resource for authoritative preclinical, clinical and post-market
drug information. These documents provide preclinical and clinical drug
development and regulatory affairs departments with a [...]

Essilor Supports the Planned Friendly Bid for Sperian Protection

CHARENTON-LE-PONT, France, March 31, 2010 – Essilor International announced today that it has signed an
agreement with the Cinven Investment Fund and Mrs. Ginette Dalloz concerning
Essilor's 15.05% stake (23.21% voting rights) in Sperian Protection.
According to the terms of the deal and subject to certain conditions, Cinven
will launch a cash tender offer for Sperian Protection through [...]

Medefield Adds Key Executives to Lead Lyon and Hamburg Offices

LONDON, March 31, 2010 – Medefield, the leading global physician and related HCP fieldwork
services provider, announces two senior appointments to lead its global
expansion, establishing offices in Lyon and Hamburg.

Anne-Beatrice Clidassou is appointed Managing Director of our office in
Lyon, France. Anne-Beatrice has over 12 years of experience in healthcare
market research. She [...]

Chiltern Announces Investment in Endpoint

LONDON, March 31, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO) announced a strategic partnership with endpoint. With this
investment, Chiltern becomes a minority shareholder in the company
established in April 2009.

Glenn Kerkhof, Chiltern CEO, stated, "Chiltern's decision to invest in
endpoint is representative of our commitment to seek collaborations [...]

Teva UK Limited Launches Temozolomide Capsules

CASTLEFORD, England, March 31, 2010 – We are pleased to announce the launch of temozolomide available in 5mg,
20mg, 100mg, 140mg, 180mg and 250mg strength capsules. Temozolomide is
indicated for the oncological treatment of brain tumours, specifically(1):

– adult patients with newly-diagnosed glioblastoma multiforme
concomitantly with radiotherapy (RT) [...]

Cellvax Expands its Preclinical Service Offers by Moving to a New Laboratory Facility With an Access to Large Animals and a Number of New Technical Plat-Forms

PARIS, March 31, 2010 – Cellvax is a French service company which provides complete in
vitro & in vivo preclinical innovating services allowing to accelerate the
drug development process for unmet needs related with severe human diseases,
mainly in oncology field.

Cellvax was created in 2001 as a French SME by a motivated and
complementary [...]

Clearstone Expands Testing Capabilities at Laboratory in Toronto

TORONTO, March 31, 2010 – Clearstone Central Laboratories, a leading global provider of clinical
laboratory and centralized cardiac services for clinical trials, today
announced the expansion of testing capabilities at its Toronto laboratory.
Additional safety as well as esoteric testing capacity and capabilities will
be added to the existing operations.

"Since the acquisition of this [...]

Debt Ridden Britain Relies on Credit for Dental Bills

ANDOVER, England, March 31, 2010 – In the last year, 39% of Britons have had to pay for dental
bills over GBP50 using a credit card, and 2% have been forced to take out a
loan. These shocking results come as even more people struggle to find an NHS
dentist for themselves and their children (up from [...]

Recent Survey Reveals Decay in Nation’s Dental Health

ANDOVER, England, April 1, 2010 – A lack of affordable dental care could have a severe effect on
the future state of Britain's teeth, according to a recent survey into the
oral health of the nation carried out by healthcare provider Simplyhealth.

Just half of the population is currently under the care of [...]

Survey Reveals the Value of Dental Benefits

ANDOVER, England, April 1, 2010 – Simplyhealth's Annual Dental Survey 2010 has highlighted the
value that HR managers now place on dental benefits. Two thirds of companies
believe dental benefits reduce sickness absence, a number that has more than
doubled since 2008 (30%). A further two thirds believe they improve morale
and aid recruitment and retention. As dental [...]

AmVac AG Granted Patent for new Vaccine Development

ZUG, Switzerland, April 1, 2010 – The Swiss company AmVac AG, a biopharmaceutical company
located in Zug, has been granted a European patent (EP 1851 239 B1) for its
Sendai platform technology for its subsidiary company AmVac Research GmbH.
Thus, the novel technology for producing vaccines that has been developed at
the research site in Martinsried near Munich, [...]

Newly Ratified ZigBee Health Care Profile Now Available for Public Download

Public availability will spur innovation in telemedicine to help people live healthier, independent lives

SAN RAMON, California, April 5, 2010 – The ZigBee(R) Alliance, a global ecosystem of companies creating wireless
solutions for use in energy management, residential, commercial and consumer
electronics applications, today announced the Board of Directors has ratified
ZigBee Health Care and made the standard [...]

West Wireless Health Institute Names Dr. Joseph Smith to Serve as Chief Medical and Science Officer

Prominent Cardiologist and Medical Device Innovator to Lead Institute's Medical Charter

SAN DIEGO, April 5, 2010 – The West Wireless Health Institute (WWHI) today announced Dr. Joseph
Smith has been named chief medical and science officer. He will be
responsible for leading the Institute's medical research and clinical-focused
activities and will assume the role immediately. Smith brings with [...]

The CPM Resource Center Launches Web-Based Clinical Practice Guidelines

Point of Care Guidelines(TM) Supports New and Emerging Meaningful use Requirements for Care Coordination and Interdisciplinary Collaboration

GRAND RAPIDS, Michigan, April 5, 2010 – The Clinical Practice Model Resource Center (CPMRC)
(www.cpmrc.com/), an Elsevier company and leader in developing
clinical practice guidelines for healthcare, today launched its first
Web-based version of Point of Care Guidelines(TM) (www.cpmrc.com/).
The online edition [...]

Breast Augmentation With Autologous Fat Stem Cells

Clinic DDr. Heinrich Leads in Breast Augmentation With Autologous Stem Cells

VIENNA, Austria, April 6, 2010 – Whereas US and European medical centers are still beginners in breast
augmentation with stem cell-enriched autologous fat, Viennese New Cosmetic
Surgery and anti-aging expert DDr. Karl-Georg Heinrich is well-versed in this
revolutionary method. In his Clinic DDr. Heinrich, he has been [...]

Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry!

LONDON, April 6, 2010 – The economic recovery process has proved difficult for the pharmaceutical
industry. Factors like patent expiry, dry pipeline, and strict approval
guidelines have slowed down the attractive drug discovery and industry
growth. Coupled with an investment risk in new therapy or molecules, this
creates a challenge for the industry to overcome. However, in the [...]

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan

TOKYO, April 6, 2010 – Daiichi Sankyo Company, Limited announced today that it has
submitted a New Drug Application to the Ministry of Health, Labor and Welfare
in Japan seeking approval of the anticoagulant, edoxaban, for the prevention
of venous thromboembolism (VTE) after major orthopedic surgery.
[...]

Clearstone Hires Quality Assurance Leader

TORONTO, April 6, 2010 – Clearstone Central Laboratories, a leading global provider of clinical
laboratory and centralized cardiac services for clinical trials, today
announced the appointment of Rose Buot as Vice President of Global Quality
Assurance. She will report directly to Clearstone CEO Lewis Cameron and work
from the company's Baillet-en-France laboratory, near Paris, France.

[...]

Accumetrics, Inc. Announces Completion of GRAVITAS Trial Enrollment

SAN DIEGO, April 6, 2010 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy to use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, announced that
it has completed the enrollment phase of its landmark clinical trial,
GRAVITAS (Gauging Responsiveness with A VerifyNow(R) Assay Impact on
Thrombosis And Safety). [...]

U.S. Market for Dental Operatory Equipment 2010 Report Now Available on ReportsandReports

DALLAS
ReportsandReports Announce it Will Carry the U.S. Market for Dental Operatory Equipment 2010 Market Research Report in its Store.

Browse the complete Report on:?? www.reportsandreports.com/market-reports/us-market-for-dental-operatory-equipment-2010/
The combined U.S. market for dental operatory equipment and practice management software was valued at $1.6 billion.
This market includes
Dental imaging systems,
Furniture and cabinetry,
Curing lights,
Autoclaves,
Microscopes
Practice management software
The dental imaging market is segmented into:
Intraoral [...]

Global Dental Consumables Market Report Now Available on ReportsandReports

DALLAS
ReportsandReports Announce it Will Carry the Global Dental Consumables Market Research Report in its Store.

Browse the complete Report on: www.reportsandreports.com/market-reports/global-dental-consumables-market/
Dental consumables form the largest segment of the dental industry, and also hold significant potential for further growth due to the increasing incidence of oral disease and growing awareness about oral care. The growth of the [...]

Gerresheimer Strengthens Business in Russia

DUSSELDORF, Germany, April 7, 2010 -

– Representative office in Moscow opened
– New support base intensifies marketing and sales
– Russia's pharma market growing dynamically

Gerresheimer AG has set up a sales office in Moscow. The new
representation centre will intensify the [...]

Research Reveals That Overnight Contact Lenses Halt Short-sightedness in Children

LONDON, April 7, 2010 – Over the past 30 years, short-sightedness has increased
significantly and now affects 42% of the population(2). As short-sightedness
is inherited, it is now it a key health issue facing families; however, the
results from a major new study into myopia control(1) have revealed that if
children are fitted with special overnight contact lenses, [...]

Cepheid Announces European Launch of GeneXpert Infinity-48 System at the 20th Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Cepheid Also to Host Integrated Symposium 'The Medical & Public Health Impact of Rapid Molecular Testing'

SUNNYVALE, California, April 7, 2010 – Cepheid (Nasdaq: CPHD) will initiate European launch of its newest
addition to the GeneXpert(R) family of molecular diagnostic testing systems,
the GeneXpert Infinity-48, at the 20th annual European Congress of Clinical
Microbiology & Infectious Diseases (ECCMID) [...]

MarketsandMarkets: In-Vitro Diagnostics BRIC Market Worth $7.3 Billion by 2014

DALLAS, Texas, April 7, 2010 – According to a new market research report, 'In-Vitro Diagnostics (IVD)
Market in BRIC (2010 – 2014) ', published by MarketsandMarkets
(www.marketsandmarkets.com), the IVD market in BRIC is expected to be
worth US$7.3 billion by 2014, growing at a CAGR of 19% from 2009 to 2014.
Market growth is driven mainly by the [...]

Film for Thought Course ‘Body & Soul: Diana & Kathy’ is a First of its Kind in the College of Direct Support Curriculum

ATLANTA, Georgia, April 7, 2010 – The College of Direct Support (CDS), an Internet-based college
for direct support professionals managed in partnership by MC
Strategies/Elsevier and the University of Minnesota's Research and Training
Center, has introduced a new genre of courses into the CDS Curriculum – "Body
& Soul: Diana & Kathy".

The story and [...]

Immupharma PLC: Best Drug Development Company, Europe – 2010

LONDON, April 7, 2010 – Dimitri Dimitriou, CEO of Immupharma, discusses the company's unique
achievements and assesses what lies ahead in The New Economy's latest video
interview, available to view here:

www.theneweconomy.com/video/473/
About World News Media
World News Media is a leading publisher of quality financial and [...]

NeuroTherm Acquires Smith & Nephew Interventional Spine Pain Management Assets

Purchase further expands NeuroTherm's reach into the US$5 Billion Global Interventional Pain Medicine Market

WILMINGTON, Massachusetts, April 7, 2010 – NeuroTherm announced today that they have acquired the Smith & Nephew PLC
(NYSE: SNN; LSE: SN) Interventional Spine Pain Management assets from Smith &
Nephew's subsidiaries. The acquired product line includes several innovative
interventional spine pain products including [...]

Lasarow Speaks at Buckingham Palace

LONDON, April 8, 2010 – Avi Lasarow, managing director of Trimega Laboratories, was invited to
speak recently (30.3.10) at a Duke of Edinburgh's Award (DofE) event at
Buckingham Palace, attended by HRH The Duke of Edinburgh.

Trimega were invited to speak as a Charter Member of the DofE.
The event was a 'Celebration of [...]

First Studies of Fossil of new Human Ancestor Take Place at the European Synchrotron

Despite its Recent Discovery, one of the Best-Preserved Hominid Fossils has Already Been Analysed with Synchrotron Light

GRENOBLE, France, April 8, 2010 – Prof. Lee Berger of the University of the Witwatersrand (South
Africa) has discovered a new species of early human ancestor in one of the
best-preserved skeletons of an hominid, dated around 1.9 million years [...]

EPDA Champions Change for People With Parkinson’s Disease in Europe

Organisation Initiates Their Broadest-Ever Parkinson's Research Project

LONDON, April 12, 2010 – To mark the first European Parkinson's Action Day, the
European Parkinson's Disease Association (EPDA) today announces the launch of
a major new investigation into the care of people with Parkinson's across 36
European countries.
The research is being undertaken as part of a [...]

Revised Version – First Studies of Fossil of new Human Ancestor Take Place at the European Synchrotron

Despite its Recent Discovery, one of the Best-Preserved Hominid Fossils has Already Been Analysed with Synchrotron Light

GRENOBLE, France, April 12, 2010 – Prof. Lee Berger of the University of the Witwatersrand (South
Africa) has discovered a new species of early human ancestor in one of the
best-preserved skeletons of an hominid, dated around 1.9 million years [...]

Epix Pharmaceuticals, Inc. Announces the May 28, 2010 Auction Sale of MS-325 MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, April 12, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties will be auctioned on May 28, 2010. The
assets of Epix were transferred to him on July 20, 2009 and he is liquidating
them for the [...]

Mounting Evidence Shows Positive Impact of Biotech Crops

Summary of Peer-Reviewed Research in Nature Biotechnology Magazine Concludes That Biotech Crops are Having a Positive Economic Impact on Farmers, Especially Those in Developing Countries

BRUSSELS, April 13, 2010 – A growing body of research evidence indicates that biotech crops are
delivering higher yields and better economic performance for farmers around
the world.
In [...]

New Data Presented at American Academy of Neurology (AAN) Annual Meeting Show Additional Patient Benefits for Daily Multiple Sclerosis Pill Fingolimod

FRIMLEY, England, April 13, 2010 – Developed for UK consumer and medical journalists

Not intended for media in Republic of Ireland
New Data Presented at the AAN Show That Treatment With Fingolimod:

– Improves Self-Reported Ability to Perform Daily Activities for People
[...]

Nutra3 Complex(R) Develops New Oral Strips – Radiant & Ageless Beauty From Within!(TM)

NEW YORK, April 13, 2010 – Nutra3 Complex(R), an exhibitor at HBA Global Expo & Conference, is
launching a new full line of fast-melting oral strips, Strip Melts(TM), in
support of their existing line of products that addresses their mission -
Radiant & Ageless Beauty – Inside and Out!

(Photo: www.newscom.com/cgi-bin/prnh/20100413/NY85467 )
[...]

RAM Founder to Receive 2010 Inamori Ethics Prize at Case Western Reserve University

CLEVELAND, April 13, 2010 – Stan Brock, the humanitarian who has been delivering free health care
worldwide through his nonprofit organization Remote Area Medical (RAM) for 25
years, will receive the 2010 Inamori Ethics Prize, awarded by the Inamori
International Center for Ethics and Excellence at Case Western Reserve
University on September 1 at the Inamori International Center [...]

Cargill’s Steviol Glycosides Dossier Receives Positive Scientific Opinion From the European Food Safety Authority

EFSA's Safety Assessment Marks Important First Step of European Union Approval and Availability of Truvia(TM) Sweetener, Zero-Calorie Sweetness From the Stevia Leaf

WAYZATA, Minnesota, April 14, 2010 – The European Food Safety Authority (EFSA) today published a Scientific
Opinion, which confirms that steviol glycosides, sweeteners extracted from
the stevia plant, are safe for use in foods and [...]

Terry Lifts Launches Harmony Range of ‘Through Floor’ Wheelchair Lifts at April NAIDEX Exhibition

KNUTSFORD, England, April 14, 2010 – Cheshire-based Terry Lifts – leading UK specialists in disability access
products – is launching its new Harmony range of wider and longer
'through-floor' wheelchair lifts throughout the Spring and Summer months of
2010.

The roll-out programme begins at Birmingham's National Exhibition Centre
on April 20-22, when the company will [...]

Simbionix Introduces Their First Mobile App for Surgical Education

CLEVELAND, Ohio, April 14, 2010 – Simbionix USA Corporation, a global leader in medical education and
minimally invasive surgery (MIS) simulator products, announces the release of
a revolutionary, interactive mobile application for training medical
professionals. The fully interactive surgical procedure course, created for a
leading medical device manufacturer, is now available from the Apple(R) App
Store(R) for use with [...]

Pall Mall Capital Advises GEERS on Majority Stake Sale to AudioNova

Hearing Aid Market on Track For High Growth and Further Consolidation
LONDON, April 14, 2010 – GEERS Horakustik, a leading European hearing aid retailer, has
completed the sale of a 75 per cent stake in its business to AudioNova
International, the hearing aid retail business owned by HAL Holding N.V.
GEERS, a leading independent retailer in the hearing [...]

Frost & Sullivan Web Conference on Continuous Glucose Monitoring in Europe: Revolutionizing Diabetes Care

LONDON, April 15, 2010 – According to the International Diabetes Federation the adult population
with diabetes in 2010 is likely to reach 55.2 million in Europe and around
285 million people worldwide. Estimates by the World Health Organisation
(WHO) also record the global increase of diabetes at an alarming rate: By
2030 the number of people with diabetes [...]

Chemotherapy-Induced Neutropenia Can Cause Additional Burden and Risk for Cancer Patients, Pan-European Survey Reveals

Despite availability of prophylactic treatments, nearly a third of patients surveyed experienced an infection during the course of their chemotherapy. Half of patients with an infection required hospitalisation as

THE HAGUE, Netherlands, April 15, 2010 – a result
Thirty percent of patients surveyed experienced an infection as a result
of chemotherapy, 45 percent [...]

D-Pharm Receives Agreement Letter on Special Protocol Assessment for DP-b99 Study – a Pivotal Phase III Trial in Acute Ischemic Stroke Patients

REHOVOT, Israel, April 15, 2010 – D-Pharm Ltd (DPRM: TASE) announced that it has reached an
agreement with the U.S. Food and Drug Administration (FDA) under the Special
Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of
its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA
agreement letter indicates that "the design and [...]

Cell Biosciences Launches Two New Platforms

SANTA CLARA, California, April 15, 2010 – Cell Biosciences, Inc., a provider of innovative protein analysis tools
to life science researchers, today announced the launch of two new platforms
for ultrasensitive protein characterization. Both platforms will be unveiled
at the American Association for Cancer Research (AACR) 101st Annual Meeting,
April 17-21, 2010 in Washington, DC (booth 719).

[...]

Growing Threat From Potentially Lethal Diseases Highlighted at Meeting of Global Experts

International Experts at Meeting in New York Call for Vets and Owners to Act

NEW YORK, April 15, 2010 – As experts from around the world met in New York this week they discussed
the need for greater understanding of the threat posed by ticks, fleas and
sand flies. Leading scientists called on veterinarians and dog-owners around
the [...]

Contura Submits Registration Application for Aquamid(R) to the FDA

SOBORG, Denmark, April 15, 2010 – Contura Inc. has submitted a Premarket Approval Application (PMA) for
Aquamid(R) to the U.S. Food and Drug Administration (FDA) requesting
marketing approval in the U.S. for the aesthetic treatment of moderate to
severe facial wrinkles and folds.

The application includes a successful U.S. pivotal study, in which the
safety [...]

Protein Potential LLC Awarded $3 Million U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Vaccine Targeting Plasmodium vivax, a Neglected Cause of Malaria

ROCKVILLE, Maryland, April 19, 2010 – Protein Potential LLC has received support from the National Institute of
Allergy and Infectious Diseases (NIAID) of the NIH in the form of a Phase II
Small Business Innovation Research (SBIR) Grant. The three-year award
totaling approximately US$3 million will support translational research to
develop a vaccine for the prevention of malaria [...]

The Astellas European Foundation Winner of Urology 2010 Prize Fund Announced

BARCELONA, Spain, April 19, 2010 – The Astellas European Foundation is delighted to announce the winner of
the 2010 Urology Prize Fund:

Professor Jenny Southgate and Dr Simon Baker from the University of York,
UK
Professor Southgate and Dr Baker received the prize fund of US$ 300,000
to support work on [...]

Teva UK Limited Welcomes DH Consultation on COPD Strategy

CASTLEFORD, England, April 19, 2010 – Teva UK Limited has welcomed the Department of Health's (DH) consultation
on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD).

As well as outlining a strategy for COPD services, the document also
incorporates a strategy for asthma management.
Says Robyn Hughes, Director [...]

What Colour is Your Underwear?

BRADFORD ON AVON, England, April 19, 2010 – Think Training & Development believe that the quality of your
life depends upon the quality of the questions you ask yourself.

Don't worry. They don't actually want to know what colour your
underwear is. Especially if it's grey. The point is, when you saw the
question [...]

Immense Opportunities in Store for the Economically Significant Healthcare Industry in Europe, Finds Frost & Sullivan

LONDON, April 19, 2010 – Healthcare has always been an area of utmost importance. It has
significant economic relevance and has been allocated a higher percent of
gross domestic product (GDP) in many countries compared to most other sectors
such as transport and communication, construction and education. Healthcare
also has a huge impact on employment, for the fact [...]

Wake Up to Nocturia

Studies Reinforce Serious Associated Risk of Nocturia
BARCELONA, Spain, April 19, 2010 – Study results discussed today at the European Association of
Urology (EAU) Congress in Barcelona have reinforced the association between
nocturia and a greater risk of falls and mortality.

In a population-representative study in Japan by Nakagawa et
al , it was concluded [...]

Health Robotics Canada Quickly Becomes Largest American I.V. Robotics Company with 15 Contracts in First 3 Months

BOZEN, Sud-Tirol, Italy, April 19, 2010 – Health Robotics today announced the outstanding results reported by one
of its American partners, Health Robotics Canada Inc. (HRCI) first trimester
of operations since its inception in December 2009. These impressive results
included new contracts in North America for seven i.v.STATION, six i.v.SOFT,
one CytoCare, and one I.V. Room of the [...]

Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R)

NEW YORK, LONDON and BERMUDA, April 19, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today
reported at the AACR 101st Annual Meeting 2010 in Washington, DC the results
from several preclinical studies of XERECEPT(R) in established models for
breast, colon and brain tumors. These animal studies were conducted at Duke
University and the Piedmont Research Center using [...]

MarketsandMarkets: BRIC Diabetes Drugs Market Worth US$8.7 Billion By 2014

DALLAS, Texas, April 20, 2010 – The report on BRIC Diabetes Drugs Market
(www.marketsandmarkets.com/Market-Reports/bric-diabetes-199.html)
analyzes the market for oral drugs and injectables in BRIC economies over the
period 2009 to 2014. The report measures and forecasts the BRIC market for
diabetes drugs; and analyzes the major market drivers, restraints, and
opportunities.

Browse more than 15 market [...]

Pipeline Insight: Small Molecule Targeted Cancer Therapies – New Targets Set to Drive Growth Now Available on ReportsandReports

ReportsandReports Announce it Will Carry Pipeline Insight: Small Molecule Targeted Cancer Therapies – New targets set to drive growth Market Research Report in its Store.

DALLAS, April 20, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/pipeline-insight-small-molecu
le-targeted-cancer-therapies-new-/
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into [...]

Government Initiatives to Encourage Adoption of Healthcare IT Solutions in Poland, Finds Frost & Sullivan

LONDON, April 20, 2010 – Various initiatives by the Polish Government, coupled with funding from
the European Union (EU), have been driving the adoption of IT systems by the
healthcare sector. The acceptance of the Euro as Poland's currency is set to
further fuel IT funding by the EU in the country.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
[...]

CPM Resource Center Selected as Clinical Content Provider for Patient Care Planning at Froedtert & Community Health

CPMRC Content and Transformation Process to Help Wisconsin-based Health System Standardize Care and Support Collaboration, Care Documentation and Evidenced-Based Practice

GRAND RAPIDS, Michigan, April 20, 2010 – The CPM Resource Center (CPMRC) (www.cpmrc.com/), an Elsevier
(www.elsevier.com/wps/find/homepage.cws_home) company and leader in
developing clinical practice guidelines for healthcare, today announced that
it will be the clinical content source for patient [...]

Agendia and Ferrer inCode Expand MammaPrint(R) Distribution Agreement to Latin America

HUNTINGTON BEACH, California and AMSTERDAM, April 20, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
it has closed an agreement with Ferrer inCode for the commercialization of
Agendia's FDA-cleared breast cancer recurrence test MammaPrint in Latin
America.

For the successful commercialization of MammaPrint, Ferrer inCode will
leverage the distribution power of [...]

Posit Science Disputes Results of the BBC Brain Training Study

Fatal Flaw in Methodology Provides Overly Generalized Findings
SAN FRANCISCO, April 20, 2010 – Posit Science (www.positscience.com), the leader in clinically
proven brain fitness programs, contests the interpretation and methodology
used in a British Broadcasting Corporation-sponsored study published in the
journal Nature.

Researchers in the BBC study found that their own cognitive training
programs, designed specifically [...]

SIRO Clinpharm Forms Alliance With VCRO, a Taiwan- based CRO

Pact enables SIRO's clients access to blooming Taiwan clinical research market

MUMBAI, India, April 21, 2010 – SIRO Clinpharm a Contract Research Organization (CRO) with a presence in
India, Western and Central Eastern Europe and the USA today announced its
alliance with Virginia Contract Research Organization Co., Ltd. (VCRO), a
Taiwan-based CRO.
VCRO has more [...]

MarketsandMarkets: Global Ophthalmology Devices Market 2009-2014 Worth US$16.2 Billion by 2014

DALLAS, Texas, April 21, 2010 – According to a new market research report, 'Global Ophthalmology Devices
Market (2009 – 2014), published by MarketsandMarkets (
www.marketsandmarkets.com), the total global ophthalmology devices
market is expected to be worth US$16.2 billion by 2014, and the U.S. market
will account for nearly 37.2% of the total revenues. The global IOL market
is expected [...]

Consider the ‘Whole-Man’ When Treating Prostate Cancer

Too Little Time Spent Discussing Emotional and Sexual Impact, Says New Survey

BARCELONA, April 21, 2010 – Health care professionals need to consider the impact of
prostate cancer on the 'whole man' rather than focusing on cancer treatment
in isolation, according to results from an international survey of prostate
cancer patients and their partners.
To [...]

Abbott Completes Acquisition of Facet Biotech

ABBOTT PARK, Illinois, April 21, 2010 – Abbott (NYSE: ABT) has completed its acquisition of Facet Biotech
Corporation, strengthening its pharmaceutical pipeline in immunology and
oncology.

The acquisition provides Abbott with a promising biologic intended to
treat multiple sclerosis (MS) and compounds that complement its existing
diverse oncology program. The new Abbott compounds include daclizumab [...]

The 5-HT3 Receptor Antagonist Aloxi(R) Launched in Japan

LUGANO, Switzerland and TOKYO, Japan, April 22, 2010 – Helsinn Healthcare SA, Switzerland, and Taiho Pharmaceutical Co., Ltd.,
Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist
palonosetron, announce the launch of Aloxi(R) injection today.

Aloxi was developed in Japan by Taiho in close cooperation
with Helsinn, based on the license agreement between Taiho [...]

Innovative Technology Could Transform Women’s Health Across Europe

Non-Invasive Treatment for Uterine Fibroids (Myoma) Given Special Recognition at the German Federal Chancellery

TIRAT CARMEL, Israel, April 22, 2010 – The ExAblate(R) 2000, a magnetic resonance guided focus ultrasound
system, received special recognition by being included in the 10th nationwide
Girls' Day in Germany. This event held on April 21st, 2010 at the German
Federal Chancellery, celebrates [...]

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

NEW YORK, LONDON and HAMILTON, Bermuda, April 22, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the
initiation of a Phase I/II pediatric dose tolerance trial to test their
investigational new drug XERECEPT(R) in pediatric patients suffering from
primary, recurrent or metastatic brain tumors.

Celtic Pharma's objective for this trial is to [...]

Exeter(R) Hip System Celebrates 40th Anniversary and Manufacture of One-Millionth Hip Stem

Surgeon-Created Orthopaedic Hip System Revolutionized Hip Implant Design, Continues to Deliver Excellent Clinical Results

EXETER, England, April 22, 2010 – Stryker Corporation's Orthopaedics Division is celebrating this month the
one-millionth manufacturing of its Exeter hip stem (
www.exeterhip.co.uk), an implant developed in collaboration with an
orthopaedic surgeon and engineer to address the problem of aseptic loosening.
This year also [...]

El Instituto Palacios acogera en Espana a becarios de Master en Climaterio y Menopausia para potenciar su formacion en Salud de la Mujer

Master en Climaterio y Menopausia, un proyecto 100% online, cuenta con el respaldo de la FLASCYM, la IMS, el CAMS, la Asociacion Espanola para el Estudio de la Menopausia (AEEM) y los especialistas de mayor prestigio internacional

MADRID, April 22, 2010 – Master en Climaterio y Menopausia(R), una iniciativa que nace
con el objetivo de dar [...]

Amira Pharmaceuticals Announces Patent Grant in United Kingdom

Patent Covers Novel DP2 (CRTH2) Receptor Antagonists for the Treatment of Respiratory Disorders

SAN DIEGO, April 22, 2010 – Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual
Property Office has granted it patent number GB2460597
(www.ipo.gov.uk/p-find-publication-result?PatentNo=GB2460597&Journal
Number=0&EarliestYear=1900&EarliestWeek=1&LatestYear=2050&LatestWeek=52&Doc
Types=A%2CA8%2CA9%2CB%2CB8%2CC%2CC2%2CC3&ResultsPerPage=2&Start=0 ) titled
"N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2
RECEPTORS."
This is the first patent granted of a large estate [...]

Colorcon Acquires Pharmaceutical Excipient Company – NP Pharm

HARLEYSVILLE, Pennsylvania, April 22, 2010 – Colorcon, Inc. today announced the acquisition of the full-service
pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This
acquisition expands Colorcon's global excipient product offerings in the
pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS(R) sugar spheres complements Colorcon's
SureSpheres(R) sugar spheres product line and barrier [...]

Statement on Behalf of Dr Sarah Myhill Concerning GMC Hearing of 29 April

LONDON, April 27, 2010 – Statement on behalf of Dr Sarah Myhill:

On Thursday 8th April 2010, Dr Sarah Myhill, a private GP, was summoned
to a GMC Hearing on Monday 12th April so that her license to practise
medicine could be suspended whilst anonymous allegations against her were
investigated. The GMC gave her [...]

Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol

HOERSHOLM, Denmark and SAN DIEGO, April 27, 2010 – — Santaris Pharma A/S selects lead research compound SPC5001 targeting
PCSK9 to advance into drug development for the treatment of high cholesterol

— PCSK9, an important new target, is a protein involved in regulating
LDL or "bad" cholesterol in the blood- a major risk [...]

G8 Development Ministers Must Heed Early Warning Signs of Cutbacks to AIDS Funding

DELHI, India and KAMPALA, Uganda, April 26, 2010 – Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the
new report from the International Treatment Preparedness Coalition (ITPC),
documents early warning signs resulting from the global pullback on AIDS
commitment and funding: caps on the number of people enrolled in treatment
programmes, more frequent drug stock outs, and [...]

Take the Stress Out of Everyday Life With Mikki!

Mikki are the Proud Sponsors of National Grooming Week in Conjunction With National Pet Month 24th April – 1st May 2010

LONDON, April 26, 2010 – Mikki, sponsors of National Grooming Week, recognise that the
bond between people and animals is a strong one and one which can actually
benefit any pet owner. Recent research carried out [...]

Health Robotics to Showcase CytoCare at ISOPP (May 2010) and Charles University’ General Faculty Hospital of Prague

BOZEN, Sud-Tirol, Italy, April 26, 2010 – Health Robotics today announced the upcoming cooperation with the
International Society of Oncology Pharmacy Practitioners (ISOPP), B|Braun
Melsungen, and the General Faculty Hospital of Prague to host ISOPP delegates
at its bi-annual congress to witness live demonstrations of CytoCare in an
Oncology patient setting. CytoCare is the only robot in the [...]

IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment

IMPLANET Raises EUR 8 Million
BORDEAUX, France, April 26, 2010 – Thanks to promising commercial debut of its products (Surgical
implants for Orthopedic and Spine surgery) and its Healthcare Information
Technologies service offer (fully integrated and automated patient/product
tracking and supply chain) IMPLANET S.A. raises an additional EUR 8 million
(USD 11 million).

IMPLANET is proud [...]

Record Attendance Expected At UBM’s Chinese Pharma Events

AMSTERDAM, April 26, 2010 – Continued double digit growth in the Chinese pharmaceutical industry is
reflected in record visitor pre-registration levels and a sell-out of
exhibition space at this year's UBM International Media China events – CPhI,
ICSE, P-MEC and BioPh – which will run from June 2-4 at the Shanghai New
International Expo Centre.

[...]

Pro-Tect, Inc. Acquires Revolutionary Drug Delivery Patents

WEST CALDWELL, New Jersey, April 26, 2010 – Pro-Tect Pharmaceuticals, Inc. (PRTT) announced today that it has
completed the acquisition of multiple patents and patents-pending from
Nectid, Inc., that enable three revolutionary drug delivery technologies.

The acquired patents would enable Pro-Tect to provide efficient,
effective drug delivery platforms for three essential yet currently unmet
needs:

[...]

GSK Awards Celebrate Unsung Excellence in Health Care

LONDON, April 26, 2010 – Ten award-winning charities will each receive GBP25,000 in
recognition of their outstanding work in addressing some of the most
difficult health issues and improving health care in some of the UK's most
deprived communities.

The GSK IMPACT Awards, a partnership with independent health
charity The King's Fund, celebrate the vital [...]

The European Commission’s FP7 Programme to Boost the Life Science R&D Funding in Europe, Finds Frost & Sullivan

LONDON, April 27, 2010 – Europe is moving towards becoming a knowledge-based economy. Keeping in
line with this objective, the European commission has instituted the
Framework 7 (FP7) programme. Launched to support the re-launched Lisbon
strategy, FP7 focuses on research themes rather than the framework programmes
of the past. It has been designed to meet some of the [...]

MarketsandMarkets: Global OLED Market Worth US$2.2 Billion by 2014

DALLAS, Texas, April 27, 2010 – According to a new market research report, 'Opportunities in the Global
OLED Display Market', published by MarketsandMarkets
(www.marketsandmarkets.com), the global OLED product market is
expected to be worth US$2.2 billion by 2014, growing at a CAGR of 24.7% from
2009 to 2014. The Asia-Pacific market is expected to account for nearly 90%
of [...]

ASP Sterrad Technology Approved by AFSSAPS for Total Inactivation of Prions

French Health Products Safety Agency AFSSAPS Approves STERRAD(R) Hydrogen Peroxide Gas Plasma Technology for Total Inactivation of Protein-based Infectious Agents Linked to Fatal Brain Diseases

PARIS, April 27, 2010 – Advanced Sterilization Products (ASP) announced today that the French
Health Products Safety Agency, AFSSAPS, will approve the low-temperature
hydrogen peroxide gas plasma STERRAD(R) NX(TM) and the STERRAD(R) [...]

Kiadis Pharma Provides ATIR(TM) Update: Two Year Follow-Up Data Show No Cases of Transplant Related Mortality

FDA Grants ATIR(TM) Orphan Drug Status as a Medicinal Cell Based Therapy to Reduce Transplant Related Mortality

AMSTERDAM, April 28, 2010 – Kiadis Pharma today provided an update on its cell therapy product
ATIR(TM) developed for mismatched bone marrow transplants. ATIR(TM) continues
to show excellent clinical results in patients who received a mismatched bone
marrow transplantation from a [...]

Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen

DUBLIN, April 27, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that it has received a Paragraph IV
Notice Letter from Anchen Pharmaceuticals, Inc. ("Anchen") advising of the
filing of an Abbreviated New Drug Application ("ANDA") for a generic version
of Shire's 1 mg, 2 mg, 3 mg, and 4 mg guanfacine [...]

Torchmark Corporation Reports First Quarter 2010 Results

MCKINNEY, Texas, April 27, 2010 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended March 31, 2010, net income was US$1.46 per share compared with US$0.91
per share for the year-ago quarter. Net operating income for the quarter was
US$1.52 per share, a 2% increase compared with US$1.49 per share for the
year-ago quarter.

[...]

Hand Hygiene is Driving the Infection Control Market: Frost & Sullivan Web Conference on the European Hand Hygiene Market

LONDON, April 28, 2010 – The 2009 outbreak of the H1N1 influenza virus, commonly known as the
"Swine Flu," has instigated various initiatives in the infection control
industry with major emphasis on the hand hygiene market. In response to rapid
industry growth, market participants are preparing to meet the growing demand
for infection control solutions and jockeying for [...]

Pitavastatin Demonstrates Sustained Efficacy, Tolerability and LDL-C Target Attainment Over 52 Weeks

Pitavastatin Represents Effective Long-Term Treatment Option for Patients With Primary Hypercholesterolaemia or Combined Dyslipidaemia

WOKINGHAM, England, April 28, 2010 – New long-term phase III data published today in Atherosclerosis
demonstrates that, of patients with primary hypercholesterolaemia or combined
dyslipidaemia who received 4mg of pitavastatin, 74% and 73.5% achieved NCEP*
and EAS* low-density lipoprotein cholesterol (LDL-C) targets at 52 [...]

Expanding Beyond the Horizon: MarketsandMarkets Forecasting and Analytics Services to Help Pharmaceuticals Companies Tap Opportunities in Emerging Markets

DALLAS, April 28, 2010 – The pharmaceutical industry across the globe is currently facing a number
of challenges, including non-productive pipelines, stringent regulatory
pathways, threat from generic drugs, and cost containment pressure from the
governments in developed markets. However, emerging markets such as the BRIC
economies (Brazil, Russia, India, and China) offer pharma companies a
valuable opportunity as these [...]

MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014

DALLAS, Texas, April 29, 2010 – According to a new market research report, 'global oncology
biomarker market', published by MarketsandMarkets
(www.marketsandmarkets.com), The global oncology biomarker market is
expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR
of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report
analyzes the oncology biomarkers [...]

Your Brain on Resveratrol

LONDON, April 29, 2010 – Can Resveratrol, the so-called miracle molecule found in red wine,
peanuts and an obnoxious plant called Chinese Giant Knotweed, actually
improve your brain function?

Scientists at Northumbria University in the UK have just published a
double-blind, peer-reviewed study in the journal, American Journal of
Clinical Nutrition, which concludes that a [...]

Shire’s Replenished Portfolio Drives Excellent Quarterly Performance

DUBLIN, April 29, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company, announces results for the three months to March
31, 2010.

Financial Highlights

[...]

Dysentery: Don’t Let it Ruin Your Time Abroad

LONDON, April 29, 2010 – Dysentery

– Dysentery is a Common Problem for Expatriates Moving Abroad
– Poor Sanitation is Often the Cause
– Following a Few Simple Tips Can Avoid Serious Illness
– MediCare International (www.medicare.co.uk) Policies Cover
Dysentery Cases
[...]

European Workers Would Trade Money for an Early Retirement

A Third of European Workers Unhappy With Government Policy to Raise Retirement Age in Their Country

ROTTERDAM, The Netherlands, April 29, 2010 – The lure of retirement is simply too much for many Europeans
with almost one in three workers (29%) saying they would prefer their
government not to raise the national retirement age, and would be [...]

Gerresheimer Well-Positioned for Further Growth

D??SSELDORF, Germany, April 29, 2010 -

– Financial Year 2009 Successfully Completed

– Good Start to the Year 2010

– Confirmation of Guidance of 2% to 4% Sales Growth for 2010
With an Operating Margin of Around 19.5%

[...]

Agilisys Awarded 10 Year Contract With General Healthcare Group – The UK’s Largest Independent Healthcare Provider

Agilisys Helps General Healthcare Group Improve Patient Services and Reduce Costs With End-to-end Management of RIS-PACS Platform

LONDON, April 29, 2010 – Agilisys, the UK's most innovative IT services and outsourcing provider,
today announced that it has been awarded a 10-year contract by General
Healthcare Group, the UK's largest independent healthcare provider, to manage
their Radiology Information Systems [...]

New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy

HUNTINGTON BEACH, California, and AMSTERDAM, April 29, 2010 – Today, at the 11th Annual Meeting of the American Society of Breast
Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced
that Breast Cancer Research and Treatment has published an important study
demonstrating the benefit of adjuvant chemotherapy for patients with a
high-risk of breast cancer recurrence according [...]

Ingrid Klingmann Joins CRF Health as Consulting Clinical Advisor

LANSDALE, Pennsylvania, April 29, 2010 – Ingrid Klingmann, MD, PhD, FFPM, FBCPM, recently joined CRF Health as
consulting Clinical Advisor. With over 20 years of experience in the clinical
trial sector, Dr. Klingmann brings a wealth of global clinical experience to
CRF Health, the electronic patient reported outcomes (ePRO) solutions
company. In her position as Clinical Advisor, Dr. [...]

Zeltia Achieves Consolidated EBITDA Break-Even in 1Q10

Yondelis(R) sales increased by 110% with respect to 1Q09
MADRID, April 29, 2010 – Consolidated revenues for Zeltia (ZEL.MC) amounted to 32.9 million euro
in 1Q10, up 49% with respect to 1Q09. Net income improved 50%.

Net revenues in biopharmaceuticals rose 90.9%, primarily due to
Yondelis(R) sales, which totalled 16.6 million euro in the [...]